Comprehensive Guide to Hepatitis Advances

Comprehensive Guide to Hepatitis Advances

1st Edition - February 1, 2023

Write a review

  • Editors: Wai-Kay Seto, Mohammed Eslam
  • Paperback ISBN: 9780323983686

Purchase options

Purchase options
Available for Pre-Order
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in a single resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on scientific advancements in understanding the disease process, and in the treatment of different groups of hepatitis. This reference is perfect for basic science researchers in the field of hepatology, practicing gastroenterologists and hepatologists, primary care physicians attending to liver disease, and medical residents undergoing specialist training in gastroenterology and hepatology.

Key Features

  • Provides comprehensive coverage of the different types of hepatitis
  • Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care
  • Discusses future development specific to different types of hepatitis

Readership

Practicing Gastroenterologists and Hepatologists and Basic science researchers in the field of Hepatology, Primary care physicians attending to liver disease, Medical residents undergoing specialist training in Gastroenterology and Hepatology

Table of Contents

  • Section 1: Hepatitis: advances in clinical evaluation
    1a. Non-invasive assessment of disease severity: biomarker
    1b. Non-invasive assessment of disease severity: image-related
    2. Conventional liver imaging
    3. Nutrition and the liver

    Section 2: Viral Hepatitis
    4. Antivirals against hepatitis: basic mechanisms
    5. Hepatitis A and Hepatitis E
    6a. Hepatitis B: Epidemiology, Natural History and Diagnosis
    6b. Hepatitis B: Treatment
    7a. Hepatitis C: Epidemiology, Natural History and Diagnosis
    7b. Hepatitis C: Treatment
    8. Hepatitis D

    Section 3: Hepatitis: metabolic, alcohol and drug-induced
    9a. Metabolic-associated fatty liver disease: Epidemiology, Natural History and Diagnosis
    9b. Metabolic-associated fatty liver disease: Pharmacological management
    9c. Metabolic-associated fatty liver disease: Non-pharmacological management
    10. Alcoholic hepatitis
    11a. Drug-induced liver injury: conventional drugs
    11b. Drug-induced liver injury: emerging drugs, herbs and health supplements

    Section 4: Hepatitis: cholestatic, genetic and autoimmune causes
    12. Primary biliary cholangitis
    13. Primary sclerosing cholangitis
    14. Autoimmune hepatitis
    15. Wilson Disease, Hemochromatosis and Alpha-1 antitrypsin deficiency

    Section 5: Hepatitis: Infections and systemic causes
    16. Systemic infections and hepatitis
    17. Human immunodeficiency virus
    18. Systemic non-infections and hepatitis
    19. Hepatitis: dual aetiologies

    Section 6: Childhood and pregnancy
    20. Hepatitis during childhood
    21. Hepatitis during pregnancy

Product details

  • No. of pages: 600
  • Language: English
  • Copyright: © Academic Press 2023
  • Published: February 1, 2023
  • Imprint: Academic Press
  • Paperback ISBN: 9780323983686

About the Editors

Wai-Kay Seto

Prof. Wai-Kay Seto, MBBS, MD, FRCP is currently a Clinical Professor in the Department of Medicine and Principal Investigator of the State Key Laboratory of Liver Research, the University of Hong Kong, Hong Kong. Prof. Seto is currently ranked by Clarivate Analytics in the top 1% worldwide by research. He has published more than 230 international journal articles and book chapters, including leading-authored articles in the Lancet, Journal of Clinical Oncology, Lancet Global Health, Journal of Hepatology, Gut, Hepatology and Clinical Infectious Diseases, majority related to research on chronic liver diseases. He was part of a Chinese Medical Association expert panel that wrote the first chronic hepatitis B guideline for primary care physicians in Mainland China.

Affiliations and Expertise

Clinical Professor, Assistant Hospital Chief Executive (Research), HKU-Shenzhen Hospital, Consultant, Medicine, HKU-Shenzhen Hospital, Hong Kong

Mohammed Eslam

Prof Eslam MBBS, MSc, PhD is currently associate professor of hepatologchinay in the Storr liver centre, Sydney University and the head of the genetics and fatty liver group at Storr Liver Centre at the Westmead Institute for Medical Research. He Heads the international liver disease genetic consortium. Prof Eslam is currently ranked by Scival in 99.901 percentile for worldwide prominence (Fatty Liver; Liver Diseases) and his papers hve FWCI 5.02 with 72.2% in top 10% journals by cite score. He has published more than 110 international journal articles and 5 book chapters, including leading-authored articles in the The Lancet, Nature genetics, Nature Communications, Nature reviews of gastroenterology and hepatology, The Lancet gastroenterology and Hepatology, Gastroenterology, GUT, Hepatology and Journal of Hepatology.

Affiliations and Expertise

Associate Professor, Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Australia

Ratings and Reviews

Write a review

There are currently no reviews for "Comprehensive Guide to Hepatitis Advances"